glp-1 receptor agonists for type 2 diabetes Schematic illustration of monoagonists, dual and triple Liraglutide is a GLP-1 Receptor

Sodium-glucose co-transporters are responsible for 97% of glucose reabsorption6 and their inhibition lowers blood glucose by increasing renal glucose excretion.4 , 5 Using SGLT-2 inhibitors increases the risk of DKA6 , 7 by decreasing daily carbohydrate availability by 20%45%,9 lowering endogenous insulin production and stimulating lipolysis that leads to ketogenesis.6 Patients who also receive insulin may decrease insulin doses in response to lower blood glucose patterns, leading to insulin deficiency

Issues with the size, shape, and number of your red blood cells an elevated fasting homocysteine level When it comes to correcting a vitamin B12 deficiency it's important to first consider why your level was low in the first place

HIF1dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells

doi: 10.5657/FAS.2011.0079

GLP-1s slow down digestion, so big meals can sit heavy in the stomach and trigger nausea

DOI: Regulatory status